Timelike entanglement entropy: A top-down approach
Physical Review D · 28.07.2025 · 112 (2)
DOI: 10.1103/vjyt-xc15 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physical Review D, online erschienen am 28.07.2025. Verfasst von Carlos Nunez und 1 weiteren Autor:innen. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Royal Society, Science and Technology Facilities Council, Mathematical Research Impact Centric Support.
Abstract (Originalsprache)
We investigate the concept of timelike entanglement entropy (tEE) within the framework of holography. We introduce a robust top-down prescription for computing tEE using the holographic duals to higher-dimensional quantum field theories—both conformal and confining—eliminating the ambiguities typically associated with analytic continuation from Euclidean to Lorentzian signatures. We present accurate analytic approximations for tEE and timelike separations in slab geometries. We establish a clear stability criterion for bulk embeddings and demonstrate that tEE serves as a powerful tool for computing conformal field theory central charges, extending and strengthening previous results. Finally, we apply our framework to holographic confining backgrounds, revealing distinctive behaviors like phase transitions.
Förderung
- Royal Society
- Science and Technology Facilities Council
- Mathematical Research Impact Centric Support
- ANRF, India
Zitieren
APA
Nunez, C., & Roychowdhury, D. (2025). Timelike entanglement entropy: A top-down approach. Physical Review D, 112(2). https://doi.org/10.1103/vjyt-xc15
Vancouver
Nunez C, Roychowdhury D. Timelike entanglement entropy: A top-down approach. Physical Review D. 2025;112(2). doi:10.1103/vjyt-xc15
BibTeX
@article{Nunez2025,
author = {Nunez, Carlos and Roychowdhury, Dibakar},
title = {Timelike entanglement entropy: A top-down approach},
journal = {Physical Review D},
year = {2025},
volume = {112},
number = {2},
doi = {10.1103/vjyt-xc15}
}
EUVIMED